MedPath

Naabak

Brand Name: Naabak

Generic Name: N-Acetyl Aspartyl Glutamic Acid Sodium Salt

Active
Registration Number

DR-XY35545

Dosage Form

Ophthalmic Solution (Eye Drops)

Issuance Date

November 16, 2023

Expiry Date

October 13, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength49mg/mL
PackagingHDPE Bottle x 5mL (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Anti-Allergy
A
Application
Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

N-Acetyl Aspartyl Glutamic Acid Sodium SaltActive
Monograph: n-acetyl aspartyl glutamic acid sodium salt

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform